News

• Walgreens Boots Alliance Inc. gained 0.8% to $11.40 after the pharmacy retailer reported results for the fiscal third quarter ending on May 31.
  
  Sales edged up to $38.99 billion from $36.35 billion, net income swung to a loss of $175 million from a profit of $344 million, and diluted earnings per share swung to a loss of 20 cents from a profit of 40 cents a year ago.
  
  Operating income in the third quarter was $53 million, compared to $111 million, and adjusted earnings per share was 38 cents, compared to 63 cents a year earlier, respectively.
  
  “Results refl More
  
  Jun 26, 2025
• Walgreens Boots Alliance Inc. gained 0.8% to $11.40 after the pharmacy retailer reported results for the fiscal third quarter ending on May 31.
  
  Sales edged up to $38.99 billion from $36.35 billion, net income swung to a loss of $175 million from a profit of $344 million, and diluted earnings per share swung to a loss of 20 cents from a profit of 40 cents a year ago.
  
  Operating income in the third quarter was $53 million, compared to $111 million, and adjusted earnings per share was 38 cents, compared to 63 cents a year earlier, respectively.
  
  “Results reflect continued improvement in our U.S. healthcare segment and benefits from our cost-savings initiatives, while we continued to see weakness in our U.S. front-end sales,” the company said in a release to investors. Less
  
  Jun 26, 2025


• Walgreens Boots Alliance Inc. eased 0.8% to $10.50 after the struggling pharmacy retailer reported results for the fiscal second quarter of 2025 ending in February.
  
  Sales increased to $38.59 billion from $37.05 billion, net loss shrank to $2.85 billion from a loss of $5.91 billion, and diluted loss per share narrowed to $3.30 from a loss of $6.85 a year ago.
  
  Sales in the first six months of fiscal 2025 climbed to $78.05 billion from $73.76 billion, net loss shrank to $3.12 billion from a loss of $5.97 billion, and diluted loss per share narrowed to $3.61 from a l More
  
  Apr 9, 2025
• Walgreens Boots Alliance Inc. eased 0.8% to $10.50 after the struggling pharmacy retailer reported results for the fiscal second quarter of 2025 ending in February.
  
  Sales increased to $38.59 billion from $37.05 billion, net loss shrank to $2.85 billion from a loss of $5.91 billion, and diluted loss per share narrowed to $3.30 from a loss of $6.85 a year ago.
  
  Sales in the first six months of fiscal 2025 climbed to $78.05 billion from $73.76 billion, net loss shrank to $3.12 billion from a loss of $5.97 billion, and diluted loss per share narrowed to $3.61 from a loss of $6.93 a year earlier. Less
  
  Apr 9, 2025

Executive/
Director

Links

YTD

Earnings

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Outstanding Shares
(In Millions) +

Financial Statements
+

SEC Filings

Financial Ratios